Skip to content

Comparison of two insulin treatments in diabetic ketoacidosis

Comparison of subcutaneous rapid acting and intravenous insulin treatments in mild and moderate diabetic ketoacidosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201610297654N3
Enrollment
44
Registered
2017-01-26
Start date
2015-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Insulin-dependent diabetes mellitus

Interventions

Intervention 1: In case group, severity of dehydration estimates in patient with mild and mod DKA and treat.After second hour of treatment ,aspart insulin(0/1 iu/kg) use, subcutaneous every 2 hours u
Treatment - Drugs
In case group, severity of dehydration estimates in patient with mild and mod DKA and treat.After second hour of treatment ,aspart insulin(0/1 iu/kg) use, subcutaneous every 2 hours until DKA has res
In control group, patients treat with regular insulin, 0/1 iu/kg, intravenous, infusion and continued until DKA has resolved

Sponsors

Hamedan University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 17 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: blood sugar>300mg/d ; PH < 3.7; urine keton +2 or more with dipstick or in urine analysis ; history of polydipsia, Frequency, Enuresis, weight loss exclusion criteria: DKA caused by infections in patients;patients with epilepsy or underline disease;patients with endocrine disorders;patients with inborn error of metabolism patients with metabolic acidosis that treated with intravenous bicarbonate in an other center; patients that PH and dehydration's become worse

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
ABG. Timepoint: Every 4 hours. Method of measurement: Peripheral blood samples.;The number of hospitalization. Timepoint: end of study. Method of measurement: The number.;ICU admission. Timepoint: end of study. Method of measurement: The number.;Sign of brain edema. Timepoint: daily. Method of measurement: Clinical.;Electrolysis imbalance. Timepoint: Every 4 hours. Method of measurement: Peripheral blood samples.;Response time to treatment. Timepoint: Every 2 hours. Method of measurement: blood sugar with glucometer and ABG.;Hpoglycemia. Timepoint: Every 2 hours. Method of measurement: blood sugar with glucometer.

Secondary

MeasureTime frame
Hypoglycemia. Timepoint: every 2 hours. Method of measurement: blood sugar with glucometer.;Electrolysis imbalance. Timepoint: every 4 hours. Method of measurement: Peripheral blood samples.;Sign of brain edema. Timepoint: every 2 hours. Method of measurement: clinical.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Saba Maher

Hamedan University Of Medical Sciences

drs_maher@yahoo.com+98 81 3264 0051

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026